INTLGNT BIO SOL (INBS)
(Delayed Data from NSDQ)
$2.00 USD
-0.02 (-0.99%)
Updated Sep 13, 2024 04:00 PM ET
After-Market: $1.98 -0.02 (-1.00%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth C Momentum D VGM
Income Statements
Fiscal Year end for Intelligent Bio Solutions Inc falls in the month of June .
All items in Millions except EPS data.
6/30/24 | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 | |
---|---|---|---|---|---|
Sales | NA | 1 | 0 | 2 | 0 |
Cost Of Goods | NA | 1 | 0 | 0 | 0 |
Gross Profit | NA | 0 | 0 | 2 | 0 |
Selling & Adminstrative & Depr. & Amort Expenses | 0 | 13 | 9 | 8 | 3 |
Income After Depreciation & Amortization | 0 | -13 | -8 | -6 | -3 |
Non-Operating Income | NA | 2 | 0 | 0 | 0 |
Interest Expense | NA | 0 | 0 | 1 | 0 |
Pretax Income | NA | -11 | -8 | -7 | -3 |
Income Taxes | NA | 0 | 0 | 0 | 0 |
Minority Interest | NA | 0 | 0 | 0 | 0 |
Investment Gains/Losses | NA | 0 | 0 | 0 | 0 |
Other Income/Charges | NA | 0 | 0 | 0 | 0 |
Income From Cont. Operations | NA | -11 | -8 | -7 | -3 |
Extras & Discontinued Operations | NA | 0 | 0 | 0 | 0 |
Net Income (GAAP) | NA | -11 | -8 | -7 | -3 |
Depreciation Footnote | 6/30/24 | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 0 | -8 | -8 | -6 | -3 |
Depreciation & Amortization (Cash Flow) | NA | 5 | 0 | 0 | 0 |
Income After Depreciation & Amortization | 0 | -13 | -8 | -6 | -3 |
Earnings Per Share Data | 6/30/24 | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 |
---|---|---|---|---|---|
Average Shares | NA | 0.08 | 0.06 | 0.04 | NA |
Diluted EPS Before Non-Recurring Items | NA | -78.03 | -136.86 | -163.27 | NA |
Diluted Net EPS (GAAP) | NA | -127.01 | -136.85 | -163.27 | NA |
Fiscal Year end for Intelligent Bio Solutions Inc falls in the month of June .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | NA | 0.82 | 0.76 | 0.80 | 0.44 |
Cost Of Goods | NA | 0.65 | 0.56 | 0.56 | 0.39 |
Gross Profit | NA | 0.18 | 0.20 | 0.23 | 0.05 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 3.13 | 2.19 | 2.76 | 2.75 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -2.95 | -1.99 | -2.53 | -2.70 |
Non-Operating Income | NA | 0.01 | 0.05 | 0.13 | 0.09 |
Interest Expense | NA | 0.04 | 0.03 | 0.04 | 0.06 |
Pretax Income | NA | -2.99 | -1.98 | -2.43 | -2.67 |
Income Taxes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | NA | -0.01 | -0.01 | -0.01 | -0.01 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -2.99 | -1.98 | -2.43 | -2.67 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -2.98 | -1.97 | -2.43 | -2.66 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 2.08 | 0.95 | 0.19 | 0.12 |
Diluted EPS Before Non-Recurring Items | NA | -1.43 | -2.07 | -12.49 | -22.93 |
Diluted Net EPS (GAAP) | NA | -1.43 | -2.07 | -12.48 | -33.61 |